Page 116 - கத்தோலிக் பல்கலைக்கழகம் ஆஃப் அமெரிக்கா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sacramento, Calif., Dec 10, 2019 / 03:31 am (CNA).- A small case study on the safety of the abortion pill reversal procedure that was cut short due to safety concerns does not accurately represent the safety and efficacy of the procedure to the public, a pro-life group has said. “Pro-abortion researchers would rather continue to mislead women about the real risks of the abortion pill regimen Mifeprex than protect them from the risks of this dangerous drug,” Dr. Tara Sander Lee, senior fellow and director of life sciences for the Charlotte Lozier Institute, said in a statement. Earlier this year, a group of researchers from the University of California at Davis attempted to study whether administering high doses of the hormone progesterone can successfully override the effects of the progesterone-blocking drug, mifepristone, the first of two pills taken in a medically induced abortion. The second drug, misoprostol, is taken up to two days later and induces labor.

United statesCatholic university of americaDistrict of columbiaRepublic ofAshley feasleyFrances mcbrayerDonald kerwinCatholic charities atlantaDepartment of homeland securityAmerican catholic churchRefugee servicesCatholic churchCatholic charities united statesUs refugee admissions programCatholic relief servicesNews briefs